Research
D2R: A growing community with a shared vision
Earlier this month, over 150 researchers from across McGill and partner institutions came together at Le Centre Sheraton for the inaugural DNA to...
April 11, 2025
Inaugural Research Canada Innovates event at The Institute a resounding success
Sold-out event united health researchers and innovators to shape the future of healthcare On March 24, 2025, The Institute proudly partnered with Research...
April 11, 2025
What links cannabis use and psychosis? Researchers point to the brain’s dopamine system
‘Our findings could help doctors and mental health professionals better educate patients about the potential risks of frequent cannabis use’ A McGill University-led...
April 11, 2025
Epinephrine could reduce hospitalizations in pediatric intensive care after a severe allergic reaction
Research confirms the use of epinephrine before arrival at the hospital significantly reduces intensive care admissions for anaphylactic reactions During a severe allergic...
April 11, 2025
Experts from the McGill International TB Centre and The Institute publish a prestigious Lancet seminar on TB
Commissioned work underscores the role of tuberculosis (TB) as a leading cause of death globally, stressing the importance of early diagnosis, comprehensive care,...
April 11, 2025
McGill discovery sheds new light on autism, intellectual disabilities
Breakthrough that stands to rewrite the textbooks on brain function could lead to treatments A new study by McGill University researchers yields insights...
April 11, 2025
Julia Burnier: Engaging patients in research
Oncology researcher is building partnerships with cancer agencies to empower patients and transform research As Program Director of the Global Oncology Program in...
April 11, 2025
Genetic sequencing project receives more than $8 million in funding
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians A project led by Ziv Gan-Or, MD, PhD,...
April 3, 2025
Anti-swelling drug reduces immune response in brain cancer patients weeks after last dose
Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy Swelling caused by brain cancer is a problem that can lead to...
April 2, 2025
GLP-1 diabetes drugs not linked to heightened suicidality risk
Despite previous concerns, findings provide reassurance about the psychiatric safety of these drugs, say researchers from the Lady Davis Institute for Medical Research...
April 2, 2025
Latest Alzheimer’s drug shown less effective in women
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi,...
April 2, 2025
COVID-19 boosters help avoid breakthrough infections in immunocompromised people, McGill-led study finds
Researchers focused on those with rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis and other immune-mediated inflammatory diseases New research findings provide solid...
April 2, 2025
AI analysis challenges autism diagnosis criteria
Researchers suggest behavioural traits are more telling than social communication and interaction factors, so diagnostic focus should be sharpened An analysis of digital...
April 2, 2025
Génome Québec and Cystic Fibrosis Canada invest $1.2 million in research tackling rare, orphan CFTR mutations
Génome Québec and Cystic Fibrosis Canada today announced a $1.2 million investment in two new research projects focused on rare genetic mutations that...
April 2, 2025